オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/01 | 1,122 | 1,135 | 1,103 | 1,117 | -13 | -1.2% | 176,200 |
2021/09/30 | 1,157 | 1,166 | 1,123 | 1,130 | -53 | -4.5% | 321,200 |
2021/09/29 | 1,168 | 1,185 | 1,158 | 1,183 | -1 | -0.1% | 172,600 |
2021/09/28 | 1,192 | 1,193 | 1,175 | 1,184 | -12 | -1% | 105,200 |
2021/09/27 | 1,209 | 1,216 | 1,191 | 1,196 | -18 | -1.5% | 84,600 |
2021/09/24 | 1,175 | 1,218 | 1,172 | 1,214 | +46 | +3.9% | 160,900 |
2021/09/22 | 1,194 | 1,210 | 1,166 | 1,168 | -26 | -2.2% | 154,700 |
2021/09/21 | 1,164 | 1,256 | 1,162 | 1,194 | -25 | -2.1% | 196,100 |
2021/09/17 | 1,202 | 1,223 | 1,195 | 1,219 | +9 | +0.7% | 88,500 |
2021/09/16 | 1,240 | 1,242 | 1,201 | 1,210 | -34 | -2.7% | 199,900 |
2021/09/15 | 1,236 | 1,251 | 1,218 | 1,244 | +6 | +0.5% | 231,400 |
2021/09/14 | 1,263 | 1,283 | 1,235 | 1,238 | -33 | -2.6% | 161,500 |
2021/09/13 | 1,250 | 1,276 | 1,244 | 1,271 | +14 | +1.1% | 152,500 |
2021/09/10 | 1,264 | 1,264 | 1,238 | 1,257 | +4 | +0.3% | 137,600 |
2021/09/09 | 1,279 | 1,295 | 1,250 | 1,253 | -35 | -2.7% | 155,200 |
2021/09/08 | 1,285 | 1,302 | 1,273 | 1,288 | +5 | +0.4% | 139,600 |
2021/09/07 | 1,299 | 1,317 | 1,281 | 1,283 | -15 | -1.2% | 155,300 |
2021/09/06 | 1,275 | 1,307 | 1,271 | 1,298 | +19 | +1.5% | 155,700 |
2021/09/03 | 1,278 | 1,300 | 1,271 | 1,279 | -3 | -0.2% | 116,500 |
2021/09/02 | 1,286 | 1,322 | 1,282 | 1,282 | -34 | -2.6% | 196,200 |
2021/09/01 | 1,270 | 1,320 | 1,260 | 1,316 | +46 | +3.6% | 171,800 |
2021/08/31 | 1,299 | 1,316 | 1,264 | 1,270 | -28 | -2.2% | 196,300 |
2021/08/30 | 1,327 | 1,327 | 1,292 | 1,298 | -13 | -1% | 198,400 |
2021/08/27 | 1,278 | 1,315 | 1,270 | 1,311 | +31 | +2.4% | 204,900 |
2021/08/26 | 1,247 | 1,287 | 1,247 | 1,280 | +34 | +2.7% | 142,000 |
2021/08/25 | 1,239 | 1,263 | 1,227 | 1,246 | +7 | +0.6% | 113,200 |
2021/08/24 | 1,256 | 1,259 | 1,225 | 1,239 | ±0 | ±0% | 149,700 |
2021/08/23 | 1,228 | 1,254 | 1,221 | 1,239 | +36 | +3% | 126,600 |
2021/08/20 | 1,213 | 1,249 | 1,201 | 1,203 | -3 | -0.2% | 179,100 |
2021/08/19 | 1,203 | 1,250 | 1,203 | 1,206 | -14 | -1.1% | 147,800 |
2021/08/18 | 1,185 | 1,221 | 1,180 | 1,220 | +37 | +3.1% | 154,900 |
2021/08/17 | 1,216 | 1,230 | 1,180 | 1,183 | -28 | -2.3% | 170,100 |
2021/08/16 | 1,239 | 1,243 | 1,200 | 1,211 | -34 | -2.7% | 175,100 |
2021/08/13 | 1,226 | 1,251 | 1,226 | 1,245 | +7 | +0.6% | 126,700 |
2021/08/12 | 1,240 | 1,256 | 1,213 | 1,238 | -2 | -0.2% | 180,400 |
2021/08/11 | 1,202 | 1,243 | 1,201 | 1,240 | +21 | +1.7% | 183,000 |
2021/08/10 | 1,158 | 1,228 | 1,125 | 1,219 | +61 | +5.3% | 334,600 |
2021/08/06 | 1,179 | 1,195 | 1,155 | 1,158 | -27 | -2.3% | 250,600 |
2021/08/05 | 1,224 | 1,239 | 1,178 | 1,185 | -39 | -3.2% | 291,900 |
2021/08/04 | 1,276 | 1,282 | 1,215 | 1,224 | -50 | -3.9% | 275,500 |
2021/08/03 | 1,257 | 1,279 | 1,254 | 1,274 | +12 | +1% | 132,400 |
2021/08/02 | 1,240 | 1,262 | 1,229 | 1,262 | +16 | +1.3% | 164,800 |
2021/07/30 | 1,290 | 1,290 | 1,227 | 1,246 | -35 | -2.7% | 261,500 |
2021/07/29 | 1,290 | 1,300 | 1,255 | 1,281 | -8 | -0.6% | 269,300 |
2021/07/28 | 1,340 | 1,376 | 1,278 | 1,289 | -51 | -3.8% | 696,400 |
2021/07/27 | 1,340 | 1,356 | 1,302 | 1,340 | +41 | +3.2% | 510,800 |
2021/07/26 | 1,320 | 1,324 | 1,288 | 1,299 | -11 | -0.8% | 231,100 |
2021/07/21 | 1,301 | 1,330 | 1,292 | 1,310 | +23 | +1.8% | 289,900 |
2021/07/20 | 1,299 | 1,358 | 1,285 | 1,287 | +15 | +1.2% | 840,700 |
2021/07/19 | 1,301 | 1,303 | 1,248 | 1,272 | -29 | -2.2% | 280,400 |
901~
950
件表示中 / 2808件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 66,400円 | +3771.0% | - | 0.00% | - | 6.01倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステムリム | 30,800円 | - | - | 0.00% | - | 2.84倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
CANBAS | 93,200円 | - | - | 0.00% | - | 5.96倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
ラクオリア | 62,800円 | +25.1% | - | 0.00% | - | 2.77倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
Chordia | 22,100円 | - | - | 0.00% | - | 4.70倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム